SGLT2 inhibitors: a novel choice for the combination therapy in diabetic kidney disease

Overview of attention for article published in Cardiovascular Diabetology, May 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 24 X posts from 24 X users, with an upper bound of 46,263 followers.

RT @mendez_bailon: Inhibidores de SGLT2 y su papel en la prevencion de la nefropatia de la #diabetes. Ayudando a los IECAs ?#Semituit https…

RT @mendez_bailon: Inhibidores de SGLT2 y su papel en la prevencion de la nefropatia de la #diabetes. Ayudando a los IECAs ?#Semituit https…

RT @mendez_bailon: Inhibidores de SGLT2 y su papel en la prevencion de la nefropatia de la #diabetes. Ayudando a los IECAs ?#Semituit https…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 20 additional X posts.